Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903213 | 6637688 | F | 5903213-2 | 20080504 | 20080925 | 20080930 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-14183008 | BRISTOL-MYERS SQUIBB COMPANY | 65 | YR | M | Y | 20080930 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903213 | 1010519765 | PS | CETUXIMAB | 2 | INTRAVENOUS | INITITED ON 26-FEB-2008 WITH 400MG/M2 | |||||
| 5903213 | 1010519766 | SS | RADIATION THERAPY | 2 | 1 DOSAGE FORM = 73.5 GY IN 35 FRACTIONS OVER 7 WEEKS INITIAL DOSE: 04MAR08 | ||||||
| 5903213 | 1010519767 | C | RANEXA | 1 | |||||||
| 5903213 | 1010519768 | C | OMEPRAZOLE | 1 | |||||||
| 5903213 | 1010519769 | C | ROBITUSSIN | 2 | |||||||
| 5903213 | 1010519770 | C | MAGNESIUM OXIDE | 2 | |||||||
| 5903213 | 1010519771 | C | PROCHLORPERAZINE | 1 | |||||||
| 5903213 | 1010519772 | C | LEXAPRO | 1 | |||||||
| 5903213 | 1010519773 | C | VYTORIN | 1 | 1 DOSAGE FORM=10/35 UNITS NOT SPECIFIED | ||||||
| 5903213 | 1010519774 | C | PLAVIX | 1 | |||||||
| 5903213 | 1010519775 | C | NADOLOL | 1 | |||||||
| 5903213 | 1010519776 | C | EXFORGE | 1 | ORAL | 1 DOSAGE FORM=5/160(UNITS NOT SPEC) | |||||
| 5903213 | 1010519777 | C | ASPIRIN | 1 | |||||||
| 5903213 | 1010519778 | C | RESTORIL | 1 | |||||||
| 5903213 | 1010519779 | C | FLOMAX | 1 | |||||||
| 5903213 | 1010519780 | C | FENTANYL TRANSDERMAL SYSTEM | 1 | TRANSDERMAL | ||||||
| 5903213 | 1010519781 | C | OXYCODONE HCL | 1 | |||||||
| 5903213 | 1010519782 | C | COMBIVENT | 1 | |||||||
| 5903213 | 1010519783 | C | DOCUSATE | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5903213 | 1010519765 | NON-SMALL CELL LUNG CANCER |
| 5903213 | 1010519766 | NON-SMALL CELL LUNG CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5903213 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5903213 | BRONCHOPLEURAL FISTULA |
| 5903213 | BURSITIS |
| 5903213 | CELLULITIS |
| 5903213 | COUGH |
| 5903213 | DYSPNOEA |
| 5903213 | PARONYCHIA |
| 5903213 | PNEUMONIA |
| 5903213 | PNEUMONITIS |
| 5903213 | PYREXIA |
| 5903213 | SEPSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5903213 | 1010519765 | 20080226 | 20080610 | ||
| 5903213 | 1010519766 | 20080304 | 20080421 |